TOPLINE: In patients with locally advanced cervical cancer receiving chemoradiation, irradiating less than whole uterus led to a low local recurrence rate and less radiation to […]

While the increased risk of cancer in patients with metabolic syndrome is well established by research, the authors of a new study delve deeper by examining […]

The US Food and Drug Administration (FDA) has approved tislelizumab-jsgr (Tevimbra, BeiGene, Ltd.) as second-line monotherapy for certain adult patients with unresectable or metastatic esophageal squamous […]

Targeted treatments, including antibody-drug conjugates and immunotherapy agents, are now standard of care for breast cancer, but there are limited data on the safety of combining […]

TOPLINE: Immunotherapy plus chemotherapy — the standard treatment for non–small cell lung cancer (NSCLC) — does not confer survival benefits over immunotherapy alone but does increase […]

The American Society for Radiation Oncology (ASTRO) recently sent a letter to the Centers for Medicare and Medicaid Services (CMS) opposing the extension of virtual supervision […]

TOPLINE: When considering a job offer at an academic radiation oncology practice, the prospective employee should focus on three key factors — compensation, daily duties, and […]

Cancer cells survive in the body because they’re able to hide from the immune system, evading the cancer-fighting T cells on constant patrol. These cancer cells […]

TOPLINE: Stereotactic ablative body radiotherapy (SABR) is a safe, noninvasive, and effective strategy for treating primary renal cell cancer (RCC) in patients not suited to undergo […]